A consumer advocacy group calls for a ban of a diabetes drug after evidence surfaces that it may increase the risk of cancer.
The Scientist
Most Recent
The FDA announces that BPA will continue to be permitted in food and beverage containers.
The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.
A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.
A new bill recently debated in the US Congress seeks to streamline the approval process for drugs.
Experts and the American public worry that the country is at risk of losing its global leadership position in scientific research.
The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
The Pediatric Research Equity Act (PREA) of 2003 requires that companies developing new drugs that could be used to treat a condition in children perform clinical trials in kids before winning FDA approval. The Best Pharmaceuticals for Children Act (
Studies on safety, efficacy, or dosing of drugs in children, or on nutritional supplements, are not run-of-the-mill.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
